1. Home
  2. SABR vs MLAB Comparison

SABR vs MLAB Comparison

Compare SABR & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sabre Corporation

SABR

Sabre Corporation

HOLD

Current Price

$1.60

Market Cap

652.0M

Sector

Technology

ML Signal

HOLD

Logo Mesa Laboratories Inc.

MLAB

Mesa Laboratories Inc.

HOLD

Current Price

$77.96

Market Cap

489.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SABR
MLAB
Founded
2006
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Industrial Machinery/Components
Sector
Technology
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
652.0M
489.8M
IPO Year
2014
1995

Fundamental Metrics

Financial Performance
Metric
SABR
MLAB
Price
$1.60
$77.96
Analyst Decision
Buy
Hold
Analyst Count
3
1
Target Price
$3.70
$94.00
AVG Volume (30 Days)
17.7M
103.3K
Earning Date
05-21-2026
05-04-2026
Dividend Yield
N/A
0.82%
EPS Growth
283.56
99.24
EPS
1.34
1.95
Revenue
$3,866,956,000.00
N/A
Revenue This Year
$7.40
$6.07
Revenue Next Year
$3.26
$5.41
P/E Ratio
$1.28
$39.90
Revenue Growth
7.46
N/A
52 Week Low
$0.81
$59.63
52 Week High
$3.63
$130.12

Technical Indicators

Market Signals
Indicator
SABR
MLAB
Relative Strength Index (RSI) 56.52 35.48
Support Level $1.20 $77.23
Resistance Level $1.70 $81.62
Average True Range (ATR) 0.20 4.13
MACD 0.04 -2.09
Stochastic Oscillator 65.13 25.90

Price Performance

Historical Comparison
SABR
MLAB

About SABR Sabre Corporation

Sabre holds the number-two air booking volume share in the global distribution system industry. The distribution segment represented 80% of total 2025 revenue and airline IT solutions 20% of revenue. The company sold its growing hotel IT solutions division to TPG in 2025 for $960 million in net proceeds. Transaction fees, which are mostly tied to volume and not price, account for the bulk of sales and profits.

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

Share on Social Networks: